Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2017 / Article
Special Issue

Biomarkers of Oxidative Stress in Experimental Models and Human Studies with Nutraceuticals: Measurement, Interpretation, and Significance 2017

View this Special Issue

Research Article | Open Access

Volume 2017 |Article ID 1672567 | https://doi.org/10.1155/2017/1672567

E. Azzini, E. Venneria, D. Ciarapica, M. S. Foddai, F. Intorre, M. Zaccaria, F. Maiani, L. Palomba, L. Barnaba, C. Tubili, G. Maiani, A. Polito, "Effect of Red Orange Juice Consumption on Body Composition and Nutritional Status in Overweight/Obese Female: A Pilot Study", Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 1672567, 9 pages, 2017. https://doi.org/10.1155/2017/1672567

Effect of Red Orange Juice Consumption on Body Composition and Nutritional Status in Overweight/Obese Female: A Pilot Study

Academic Editor: Maura Palmery
Received10 Jan 2017
Accepted01 Mar 2017
Published20 Mar 2017


The main objective of this research was to determine whether a commercial orange juice rich in anthocyanins could have an effect on body weight and on clinical parameters related to obesity including antioxidant status, lipid profile, and metabolic and inflammatory biomarkers. 11 women with an average BMI of kg/m2 were enrolled in a pilot study. Over a period of 12 weeks they received 500 mL daily dose into two doses (250 mL) of commercial red orange juice (COJ). The biochemical parameters were measured at baseline and at the end of the study (12 weeks). One month later upon free diet, a follow-up was performed measuring the same variables. The daily consumption of 500 mL of COJ had no significant effects on body weight, while there was a decrease in total cholesterol and LDL cholesterol. The grade of obesity implies different changes in inflammation biomarkers. In obese women, our data do not seem to support evidence that commercial red orange juice consumption acts as functional food preventing obesity and metabolic disorders such as insulin resistance and/or inflammatory status.

1. Introduction

Obesity is well recognized as one of the major public health issues worldwide and its prevalence is increasing [1, 2]. Overweight and/or obesity rates in Italy, like other Western countries, are estimated to be 32% and/or 10%, respectively [3]. Obesity with fat accumulation in the abdominal area, especially in the visceral compartment, may be associated with a higher prevalence of diabetes mellitus, hypertension, dyslipidemia, and coronary heart disease than gluteal-femoral obesity. The specific etiopathogenetic mechanism is not clear, although some evidence suggests that, as a major endocrine and secretory organ, visceral adipose tissue could play a key role in these metabolic complications releasing several hormones, cytokines, and other vasoactive substances [4, 5].

Obesity is commonly caused by eating excessive calories more than energy requirement needs for a long time. As widely known food intake and energy expenditure are regulated by complex interactions between the individual’s genetic background and environmental factors [6].

In humans, it is estimated that genes are responsible for only 40% in determining body mass changes while the increased prevalence of obesity in the last 20 years is mainly due to environmental factors in determining high energy intake and low energy expenditure. Lifestyles have become increasingly more sedentary leading to positive energy balance and weight gain.

Recently it was shown that preventing some metabolic disorders associated with obesity, such as diabetes mellitus, was possible by diet and lifestyle modification [7, 8].

In particular, several epidemiological studies confirmed an inverse association between higher fruit and vegetable consumption and the occurrence of cardiovascular disease, cancer, and chronic-degenerative disease [913]. Fruits and vegetables supply vitamins, minerals, trace elements, and dietary fiber and contain a unique combination and amount of compounds called nutraceuticals or phytochemicals with surprising beneficial properties (nutritional and pharmacological). Various phytonutraceuticals with antioxidant properties are able to counteract the inflammatory processes, to delay aging processes and to slow cellular degeneration.

Recently, of great interest is the dietary consumption of the anthocyanins, a water-soluble pigments belonging to flavonoids class. Their most recognized properties are to confer a wide range of colors with red, blue, purple, and violet in many fruits and vegetables and to exert potential health benefits in the free-radical scavenging, antioxidant capacities and antibacterial activity [1416].

Accumulated research evidence has also highlighted the anthocyanins’ role in rats supplemented by anthocyanin-rich diet, in the improvement of blood lipids, ameliorated inflammation, greater decrease in body weight, and better weigh control [1719].

Few studies were designed to verify the lipid-lowering and/or antioxidative capacity as well as blood glucose and blood pressure control by anthocyanins intake in humans [2022], while how these bioactive components could be implicated in regulating body weight is not completely clear.

In view of the foregoing considerations, to improve the knowledge and to highlight the health-promoting properties of anthocyanin rich foods, the effect of red orange juice consumption on nutritional anthropometry and on nutritional/metabolic status (blood lipids, vitamin, and hormonal and antioxidant status) in overweight/obese women was studied in a pilot study.

2. Materials and Methods

2.1. Red Orange Juice

A commercial pasteurized red orange juice (COJ) produced by Ortogel (Catania, Italy) was used as the anthocyanins source. Table 1 shows the energy and nutrients provided by 100 mL of COJ as reported by Ortogel. Frozen blood orange juice was given every 15 days to each participant and stored at 4°C before consumption.

Energetic value (kJ)188

Total soluble solids (°Brix)11.2
Proteins (g)0.6
Fats (g)0.1
Carbohydrates (g)10.0
Vitamin C (mg)55
Anthocyanins (mg)>50

amount on data fixed by Ortogel.
2.2. Subjects

The study was conducted in accordance with the Declaration of Helsinki on the human trial performance and informed consent was provided by participants. They were informed about the research purpose and procedure, benefits, and risks, having the freedom to drop out from the study at any time. The study protocol was approved by the Ethical Committee of the San Camillo Forlanini Hospital in Rome. In this study, the mean age of the enrolled women was 36 ± 7 years, while an average BMI of  kg/m2 indicates a presence of obesity. Overweight and/or obese women were recruited from San Camillo Forlanini Hospital and primary care physicians. Volunteers were screened considering the following exclusion criteria: presence of pathological conditions representing a risk for volunteers or likely to influence the outcomes, use of vitamin and/or mineral supplements or drugs in the last 3 months prior to the study, unusual dietary habits (vegetarians, vegans), regular consumption of alcohol > 20 g/day, and smoking habits. Information concerning medical and surgical history and use of drugs or nutritional supplements was collected by a general interview, as well as data on smoking and alcohol consumption. Anthropometric measurements (height and body weight) were performed in the morning in fasting conditions according to the standardized procedure [23]. After this screening, 20 adult women were enrolled, six volunteers declined to participate, three of them dropped out of the study, and the final sample was of 11 subjects.

2.3. Study Design

The 12-week study was a controlled feeding trial conducted by daily intake of blood orange juice. Table 2 summarizes the experimental design. According to literature data and on the basis of juice composition, enrolled subjects drunk 500 mL daily dose (two doses of 250 mL) before mealtime, corresponding to 250 mg of anthocyanins/day. Systolic and diastolic blood pressure and anthropometric measurements were performed before, every four weeks over intervention phase and at the end of COJ consumption. Biochemical parameters were measured at baseline and at the end of the study including the assessment of blood lipids and vitamin and hormonal and antioxidant status. One month later upon free diet, a follow-up was conducted on the same variables. Furthermore, subjects were asked to maintain their usual physical activity, lifestyle, and diet. Monitoring of diet was periodically carried out by 4 days of dietary records collected every 15 days; food intake data were converted into nutrient intake using the Italian food composition tables [24]. Information concerning medical conditions, use of drugs, or nutritional supplements was collected by a general interview, as well as data on lifestyle including smoking and alcohol consumption.

Baseline2 weeks4 weeks6 weeks8 weeks10 weeks12 weeksFollow-up

Medical examinationxxxxx
Anthropometric measurementsxxxxx
Blood withdrawnxxx
Lifestyle questionnairex
Food diaryxxxxxxxx

2.4. Methodologies

Anthropometric measurements including body weight, stature, circumferences, and skinfold thicknesses were assessed in accordance with the techniques described by Lohman et al. (1988).

Systolic and diastolic blood pressure was measured in mm Hg using Omron M6 (HEM-7001-E), after subjects had been resting for approximately 8–10 minutes.

Blood samples were collected in EDTA or heparin containing tubes. After centrifuging at 3000 rpm in refrigerate conditions the plasma was obtained and then stored at −80°C until analyses. Aliquots of plasma were used as shown below. Plasma Total Antioxidant Capacity was measured using Ferric Reducing Antioxidant Power (FRAP) method [25]; plasma Vitamins A and E determinations were carried out by HPLC as previously described by Maiani et al. [26]. Total ascorbic acid was extracted using the method described by Margolis and Schapira [27] and the quantitative analysis was performed using an HPLC system equipped with a coulometric detector (ESA model 580; Chelmsford, MA, USA) [28]. Total cholesterol, HDL cholesterol, triglycerides, and uric acid concentrations were measured using enzymatic tests (Sentinel Diagnostics, Milano, Italy). LDL cholesterol was estimated by the Friedewald’s formula. CRP, TNF-alpha, leptin, adiponectin, and insulin levels were measured by ELISA using commercial kits (DRG International, Inc., BD Biosciences ELISA reagent and Boster Biological Technology, Ltd.). The homeostasis model assessment-estimated insulin resistance (HOMA-IR) was used to assess insulin resistance. HOMA-IR was calculated multiplying fasting plasma insulin (mU/L) by fasting plasma glucose (mg/dL) and then dividing by the constant 405 [29].

2.5. Statistics

The results are presented as means with their standard error. Differences between the end and the start of COJ consumption are given as means and their 95% confidence intervals (95% CIs). All data were tested for normal distribution using the Kolmogorov-Smirnov test. Difference between two phases on same variable was analysed by Paired -test. Multiple-comparison post hoc correction by Bonferroni was applied. Nonnormal data were analyzed using nonparametric Kruskal-Wallis test. Results were considered significant at .

3. Results

No significant changes were observed in body weight on daily consumption of 500 mL of COJ at the end of a 12-week intervention (0.4 kg; 95% CI: −2.7 to 3.96) (Table 4). Figure 1 shows the mean changes in body weight in association to energy intake. Although no significant differences in energy intake were present during the study, the small changes observed in body weight seem to follow the trends in energy intake. Furthermore, after COJ consumption, over one-month follow-up following free diet, an increase in body weight (about 1%), despite decreasing in energy intake, was observed.

Habitual energy, macronutrient, and micronutrient intake over a 12-week supplementation phase and one month later upon free diet (follow-up) are reported in Table 3.

Before COJAfter COJFollow-up

Energy (kJ/die)5623 ± 3705704 ± 375489 ± 426
Proteins (g/die)64 ± 455 ± 356 ± 2
Lipids (g/die)58 ± 456 ± 854 ± 5
PUFA (g/die)5.2 ± 1.94.9 ± 1.0
MUFA (g/die)8.7 ± 1.29.2 ± 2.08.5 ± 1.0
SFA (g/die)14.7 ± 1.214.8 ± 1.712.8 ± 1.4
Carbohydrates (g/die)145 ± 17165 ± 11154 ± 14
Anthocyanins (mg/die)52 ± 841 ± 535 ± 6
Ascorbic acid (mg/die)78 ± 1762 ± 1167 ± 8
Fibra11.6 ± 1.311.0 ± 1.011.9 ± 0.4
Iron (mg/die)6.75 ± 0.496.53 ± 1.476.82 ± 1.40
Calcium (mg/die)406 ± 41324 ± 50422 ± 46
Retinol eq. (μg/die)714 ± 101686 ± 114916 ± 201
α-Tocopherol (mg/die)8.51 ± 0.888.94 ± 1.159.12 ± 0.87

Data are expressed as mean ± SE.
No statistical difference between phases.

Before COJAfter COJ  
(95% CI)

Body weight (kg)87.8 ± 4.588.9 ± 4.5n.s.0.4 (−2.7 to 3.96)
BMI (kg/m2)34.4 ± 1.434.6 ± 1.5n.s.0.2 (−1.2 to 1.7)
Waist circumference (cm)96.0 ± 2.996.0 ± 3.0n.s.−0.0 (−5.6 to 6.3)
Hip circumference (cm)119.38 ± 3.0119.06 ± 3.16n.s.−0.3 (−4.2 to 3.0)
WHR0.807 ± 0.020.808 ± 0.02n.s.0.007 (−0.011 to 0.06)

Data are expressed as mean ± SEM; n.s., not significant.
ANOVA: after COJ versus before COJ.
: differences from after to before COJ (mean values and their 95% confidence intervals).
WHR: waist/hip circumferences.

According to dietary survey, no significant differences in habitual diet were observed. However, it should be taken into account that the orange juice consumption led to an increasing daily calories intake (+940 kJ/die), which inevitably affect the body weight, if a decreased energy intake or increased physical activity level are not implemented.

Table 5 displays some biochemical and hemodynamic parameters over COJ consumption (12 weeks) and one month later upon free diet (follow-up). COJ consumption determined a decrease corresponding in a mean value of −11 mg/dL (95% CI: −55 to 7) in total cholesterol levels and a significant decrease in LDL-cholesterol levels −9 mg/dL (95% CI: −30 to 12; ). Moreover, over one month after COJ consumption (follow-up), moderate increases in total cholesterol (164 ± 14 versus 158 ± 13 mg/dL, resp.), triglycerides (123 ± 20 versus 106 ± 16 mg/dL, resp.), and uric acid levels ( versus  mg/dL, resp.) were highlighted in addition to a significant increase ( versus μg/dL, resp.; ) in vitamin A and a decrease ( versus  mg/dL, resp; ) in vitamin E. Moreover a significant decrease in diastolic blood pressure (74 ± 2 versus 83 ± 3 mmHg, resp.; ) was evidenced over follow-up. Measures of total ascorbic acid ( mg/dL), ascorbate ( mg/dL), and dehydroascorbate ( mg/dL) were higher after COJ consumption respect baseline (, , and  mg/dL, resp.).

Before COJAfter COJ  
(95% CI)
Follow up

Systolic pressure (mmHg)125 ± 5131 ± 5n.s.6 (−15 to 16)122 ± 4n.s.
Diastolic Pressure (mmHg)81 ± 283 ± 3n.s.3 (−10 to 10)74 ± 20.01
FRAP (μmolFe2+/L)832 ± 45827 ± 42n.s.−5 (−93 to 116)841 ± 61n.s.
Uric acid (mg/dL)4.6 ± 0.44.4 ± 0.4n.s.−0.2 (−0.9 to 1.0)4.7 ± 0.4n.s.
Total cholesterol (mg/dL)170 ± 14158 ± 13n.s.−11 (−55 to 7)164 ± 14n.s.
Triglycerides (mg/dL)104 ± 21106 ± 16n.s.3 (−108 to 89)123 ± 20n.s.
HDL-cholesterol (mg/dL)66 ± 363 ± 2n.s.−3 (−15 to 4)65 ± 2n.s.
LDL-cholesterol (mg/dL)83 ± 1274 ± 130.046−9 (−30 to 12)74 ± 13n.s.
Vitamin A (μg/dL)52.1 ± 8.349.4 ± 7.5n.s.−2.7 (−22.5 to 7.6)53.0 ± 8.00.04
Vitamin E (mg/dL)1.32 ± 0.161.28 ± 0.16n.s.0.08 (−0.40 to 0.33)1.24 ± 0.160.007
Vitamin C (mg/dL)1.01 ± 0.051.18 ± 0.08n.s.0.17 (−0.16 to 0.62)1.06 ± 0.09n.s.
AA (mg/dL)0.59 ± 0.070.64 ± 0.12n.s.0.06 (−0.42 to 0.69)0.52 ± 0.07n.s
DHA (mg/dL)0.42 ± 0.080.53 ± 0.07n.s.0.115 (−0.52 to 0.44)0.54 ± 0.07n.s

Data are expressed as mean ± SEM; n.s., not significant.
AA: ascorbic acid; DHA: dehydroascorbic acid.
: differences from after to before COJ (mean values and their 95% confidence intervals).

Metabolic and inflammatory biomarkers over 12 weeks of COJ consumption and follow-up are presented in Table 6. A mean increase of 4.8 mg/dL (95% CI: −5.6 to 20.5) in glucose levels compared to baseline was present ( versus  mg/dL, resp.). Furthermore, higher HOMA-IR of 0.6 (95% CI: −0.5 to 4.1) and higher leptin of 3.6 mg/dL (95% CI: −12.1 to 20.6) with lower adiponectin of −1.6 μg/mL (95% CI: −8.5 to 4.3) levels were associated with consumption of COJ. In addition, an increased inflammatory response was present upon consumption of COJ.

Before COJAfter COJ  
(95% CI)

Leptin (mg/dL)29.0 ± 4.432.6 ± 4.1n.s.3.6 (−12.1 to 20.6)31.2 ± 4.2n.s.
Adiponectin (μg/mL)9.54 ± 1.337.90 ± 1.08n.s.−1.6 (−8.5 to 4.3)7.66 ± 1.06n.s.
Glucose (mg/dL)100.9 ± 1.9105.7 ± (−5.6 to 20.5)105.7 ± 2.7n.s.
Insulin (mU/L)10.6 ± 1.712.2 ± 2.1n.s.1.7 (−2.3 to 15.2)11.4 ± 1.6n.s.
HOMA-IR2.61 ± 1.273.16 ± 0.54n.s0.6 (−0.5 to 4.1)3.00 ± 0.47n.s.
CRP (μg/mL)4.45 ± 1.395.91 ± 1.85n.s1.5 (−1.2 to 6.5)6.10 ± 1.73n.s
TNF-α (pg/mL)33.24 ± 3.1033.69 ± 2.69n.s0.4 (−10.7 to 20.4)37.58 ± 2.03n.s

Data are expressed as mean ± SEM; n.s., not significant.
: differences from after to before COJ (mean values and their 95% confidence intervals).

Whereas no relationship was demonstrated between several parameters and BMI, to explore the possible influence of BMI on some variables, a further assessment was performed by distributing the results obtained at the end of supplementation by BMI classes. Indeed [30], as reported in Figure 2, a clear relationship between body mass classes (<30, 30–35, >35 kg/m2) and CRP increments with respect to baseline was relieved (−μg/mL, −μg/mL, and μg/mL, resp.). Similar trend was present for TNF-α increments − pg/mL,  pg/mL, and  pg/mL, respectively, by BMI classes. Moreover, Figure 3 reports the pattern of changes by BMI classes over 12-week COJ consumption in leptin and adiponectin levels. Subjects with the highest BMI classes showed a lower increase in leptin ( versus ; versus ; 18.3±9.3 versus 13.6±9.3, resp., for BMI <30, 30–35, and >35 kg/m2) as well as lower decrease in adiponectin levels.

4. Discussion

There is growing scientific interest in the nutraceuticals and functional foods and their potential protective effects on human health, both in prevention and in treatment of obesity and cardiovascular diseases. The orange juice contains a set of powerful bioactive molecules including flavonoids, carotenoids, vitamin C, folate, and other phytochemical compounds. It is also well known that COJ contains a high concentration of anthocyanins particularly cyanidin-3-glucoside, which seems to be implicated in the reduction of body weight and fat accumulation. The effect of COJ consumption on weight gain is controversial, especially because of its sugar content [31, 32]. In this study, COJ consumption resulted in augmented carbohydrates intakes with respect to baseline and one month later on free diet (follow-up). Experimental studies in animal models have shown a probable role of anthocyanins to attenuate obesity producing a decreased weight and adipose tissue and ameliorate insulin resistance [19, 3335]. Previous studies on humans [36, 37] did not find significant anthropometric changes after regular orange juice consumption. Basile et al. [38] found a significant reduction in waist circumference in women over 8 weeks following COJ consumption but not in men. In addition, despite the higher fat intake among women, which could increase total cholesterol and LDL-cholesterol, there were important changes/improvement in their lipid profile. Same effect was reported by Dourado and Cesar [37]; an improvement of the lipid profile, evidenced by a reduction in total cholesterol and LDL-cholesterol in overweight subjects following COJ consumption, was observed, even if significant decreased lipids consumption was present. Total cholesterol and LDL-cholesterol levels decreased in our sample with slightly increase in dietary lipids, while triglycerides and HDL-cholesterol were unchanged. The absence in reducing triglyceride levels seems to confirm the primary effect due to gender, fasting glucose, insulin levels, insulin resistance, and total fructose intake [39]. In addition we failed to detect a raising HDL-cholesterol levels after COJ consumption was found in previous studies on humans [37, 38, 40]. Only two overweight subjects exhibited an increase of 3% with respect to HDL-cholesterol levels after COJ consumption (70 ± 4 versus 68 ± 4 mg/dL), while a mean reduction of 5% was present in subjects with a BMI > 30 kg/m2 (63.5 ± 3 versus 66.5 ± 3 kg/m2) (data not shown). These different outcomes may be explained by type of administration (fresh and/or commercial product or pure compound), dose, length of the study, and different sizes and clinical characteristics of the enrolled sample. In agreement with several studies, other components rather than or in addition to anthocyanins may contribute to enhancing lipid profile and to exert beneficial antiobesity effects [36, 41]. As it is well known, the obesity corresponds to a subclinical inflammatory condition that promotes the production of proinflammatory factors involved in the pathogenesis of insulin resistance [42]. Our sample at baseline was characterized by overproduction of proinflammatory mediators, such as circulating levels of C-reactive protein (μg/mL), TNF-α ( pg/mL), and insulin resistance (HOMA-IR ) and normal lipid profile, several of which are risk factors for cardiovascular diseases, metabolic syndrome, and diabetes. The only two overweight subjects showed a mean decrease of 34% and 23%, respectively, for CRP and TNF-α levels, while, among women with obesity (BMI > 30 kg/m2), mean increase of 39% and 5% was present, respectively. Thus, different grade of obesity implied different changes in inflammation biomarkers. The increase in blood glucose observed at 12 weeks after supplementation ( mg/dL) compared to baseline ( mg/dL) could be attributed to sugars contained in COJ (50 g/day), which may have influenced the plasma glucose levels as well as body weight (88.9±4.9 versus 87.8±4.5 kg). Factors associated with diet of subjects should be excluded because there were no significant changes throughout the study. In spite of increases of the ascorbate and dehydroascorbate levels, COJ consumption causes an increase of the DHA/AA ratio (83%) compared to baseline (72%). As reported [43] higher ratio may relate to the varied metabolic roles of the vitamin instead of inadequate dietary vitamin C intake. On the other hand, the decrease of uric acid and vitamin E seem to justify the decline in the levels of FRAP which contribute to the 60% and 5%, respectively [25].

Li et al. [44] have demonstrated that anthocyanin supplementation exerts beneficial metabolic effects in subjects with type 2 diabetes by improving dyslipidemia, enhancing antioxidant capacity, and preventing insulin resistance. Asgary et al. [45] have reported beneficial effects on the physiological characteristics of healthy volunteers particularly in some of inflammatory markers after the consumption of commercial and fresh orange juice. In our study, COJ consumption in obese women was associated with increased metabolic abnormalities associated with insulin resistance; only two overweight subjects showed a HOMA-IR value < 2.2 associated with a reduction of 14% after 12 weeks of COJ consumption. Obese women (>30 kg/m2) showed a mean increase of 39% in HOMA-IR value at the end of supplementation phase ( versus ). Higher plasma leptin concentrations ( versus  mg/dL) and lower adiponectin levels ( versus μg/dL) were highlighted suggesting increased obesity-related complications. In fact, proinflammatory mediators such as TNF-α and CRP slightly increased, as well as a decreased antioxidant status including FRAP, uric acid, vitamin A, and vitamin E which is evidenced. As reported by Fantuzzi [5], the mechanism by which the insulin-resistant state is associated with low levels of adiponectin is not clear while its anti-inflammatory role appears confirmed. Adiponectin reduces the production and activity of TNF-α; in contrast, in obese subjects increased TNF-α production could explain the decline of adiponectin levels. Hajri et al. [46] have reported that reduced insulin stimulation and increased TNF-α production are among the factors that contribute to the decline of adiponectin production and alteration of isomer composition in obese insulin-resistant subjects. Furthermore, some evidence indicates that TNF-α is an important player in the state of insulin resistance observed during obesity by interfering with insulin signaling [47]. Castro et al. [48] highlighted a probable pathophysiological and molecular mechanisms involved in the link between increased visceral adipose tissue, insulin resistance, and comorbidities. The mechanisms involved in the etiopathogenesis of insulin resistance related to obesity occur due to prereceptor, receptor, and/or postreceptor impairments, mainly to insulin receptor downregulation secondary to hyperinsulinemia (receptor) and inhibition of the intracellular cascades by several adiposity-related factors (e.g., impaired adipokines and/or cytokines secretion) (after receptor) [49]. At last, our data support the evidenced strong relationship between leptin and adiponectin as well as their modulation by BMI and dietary pattern diet; the linkage between leptin resistance and obesity was confirmed, too.

5. Conclusion

Although our research is a pilot study at low subjects stratifying by BMI classes and our findings cannot be generalized, they might be helpful in planning further studies design and supplementary knowledge.

In obese women our data do not seem to support evidence that COJ consumption acts as functional food and could be consumed as part of a healthy diet to prevent obesity and metabolic disorders such as insulin resistance and/or inflammatory status. We confirm the role of adipose tissue as endocrine and secretory organ in releasing adipokines and proinflammatory molecules. The grade of obesity implies different changes in inflammation biomarkers. Our findings support the hypothesis that COJ consumption was significantly associated with favorable effects on total cholesterol and LDL-cholesterol levels in subjects with normal lipid profile.

In the light of the aforementioned considerations and results we suggest the consumption of freshly squeezed orange juice, without added sugars in obese women as part of a controlled diet or alternatively taking into account the global energy diet. The combination with increasing physical activity for maintaining a healthy body weight through healthier food choices could improve the comorbidities related to the obesity.

Conflicts of Interest

The authors declare that they have no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

All authors have made substantial contribution to this work. All authors have read and approved the final paper.


This study was supported by the Italian Ministry of Agricultural, Food and Forestry Policies in the framework of the Biovita and Terravita Projects.


  1. World Health Organization, The World Health Statistics 2014, World Health Organization, Geneva, Switzerland, 2014.
  2. “Anno 2015 Fattori di rischio per la salute : fumo, obesità, alcol e sedentarietà,” 2016, http://www.istat.it/. View at: Google Scholar
  3. Sistema di Sorveglianza PASSI, Progressi delle Aziende Sanitarie per la Salute in Italia. Obesity Day 2015: scheda “Sovrappeso e obesità in Italia: dati Passi (2011–2014)”.
  4. J. Galgani and E. Ravussin, “Energy metabolism, fuel selection and body weight regulation,” International Journal of Obesity, vol. 32, supplement 7, pp. S109–S119, 2008. View at: Publisher Site | Google Scholar
  5. G. Fantuzzi, “Adipose tissue, adipokines, and inflammation,” Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 911–919, 2005. View at: Publisher Site | Google Scholar
  6. W. Routray and V. Orsat, “Blueberries and their anthocyanins: factors affecting biosynthesis and properties,” Comprehensive Reviews in Food Science and Food Safety, vol. 10, no. 6, pp. 303–320, 2011. View at: Publisher Site | Google Scholar
  7. F. B. Hu, “Globalization of diabetes: the role of diet, lifestyle, and genes,” Diabetes Care, vol. 34, no. 6, pp. 1249–1257, 2011. View at: Publisher Site | Google Scholar
  8. M. Asif, “The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern,” Journal of Education and Health Promotion, vol. 3, article 1, 2014. View at: Publisher Site | Google Scholar
  9. D. O. McCall, C. P. McGartland, M. C. McKinley et al., “Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner,” Circulation, vol. 119, no. 16, pp. 2153–2160, 2009. View at: Publisher Site | Google Scholar
  10. F. J. He, C. A. Nowson, M. Lucas, and G. A. MacGregor, “Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies,” Journal of Human Hypertension, vol. 21, no. 9, pp. 717–728, 2007. View at: Publisher Site | Google Scholar
  11. J. H. John, S. Ziebland, P. Yudkin, L. S. Roe, and H. A. W. Neil, “Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial,” The Lancet, vol. 359, no. 9322, pp. 1969–1974, 2002. View at: Publisher Site | Google Scholar
  12. B. Buijsse, E. J. M. Feskens, M. B. Schulze et al., “Fruit and vegetable intakes and subsequent changes in body weight in European populations: results from the project on Diet, Obesity, and Genes (DiOGenes),” American Journal of Clinical Nutrition, vol. 90, no. 1, pp. 202–209, 2009. View at: Publisher Site | Google Scholar
  13. P. Boffetta, E. Couto, J. Wichmann et al., “Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC),” Journal of the National Cancer Institute, vol. 102, no. 8, pp. 529–537, 2010. View at: Publisher Site | Google Scholar
  14. S. Khurana, K. Venkataraman, A. Hollingsworth, M. Piche, and T. C. Tai, “Polyphenols: benefits to the cardiovascular system in health and in aging,” Nutrients, vol. 5, no. 10, pp. 3779–3827, 2013. View at: Publisher Site | Google Scholar
  15. E. Azzini, G. Maiani, I. Garaguso et al., “The potential health benefits of polyphenol-rich extracts from Cichorium intybus L. studied on caco-2 cells model,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1594616, 9 pages, 2016. View at: Publisher Site | Google Scholar
  16. R. Acquaviva, A. Russo, F. Galvano et al., “Cyanidin and cyanidin 3-O-β-D-glucoside as DNA cleavage protectors and antioxidants,” Cell Biology and Toxicology, vol. 19, no. 4, pp. 243–252, 2003. View at: Publisher Site | Google Scholar
  17. F. J. Alarcon-Aguilar, A. Zamilpa, M. D. Perez-Garcia et al., “Effect of Hibiscus sabdariffa on obesity in MSG mice,” Journal of Ethnopharmacology, vol. 114, no. 1, pp. 66–71, 2007. View at: Publisher Site | Google Scholar
  18. A. L. Molan, M. A. Lila, and J. Mawson, “Satiety in rats following blueberry extract consumption induced by appetite-suppressing mechanisms unrelated to in vitro or in vivo antioxidant capacity,” Food Chemistry, vol. 107, no. 3, pp. 1039–1044, 2008. View at: Publisher Site | Google Scholar
  19. T. Tsuda, “Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome,” Journal of Agricultural and Food Chemistry, vol. 56, no. 3, pp. 642–646, 2008. View at: Publisher Site | Google Scholar
  20. M. Murkovic, P. M. Abuja, A. R. Bergmann et al., “Effects of elderberry juice on fasting and postprandial serum lipids and low-density lipoprotein oxidation in healthy volunteers: a randomized, double-blind, placebo-controlled study,” European Journal of Clinical Nutrition, vol. 58, no. 2, pp. 244–249, 2004. View at: Publisher Site | Google Scholar
  21. A. E. Banini, L. C. Boyd, J. C. Allen, H. G. Allen, and D. L. Sauls, “Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects,” Nutrition, vol. 22, no. 11-12, pp. 1137–1145, 2006. View at: Publisher Site | Google Scholar
  22. P. Castilla, R. Echarri, A. Dávalos et al., “Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects,” American Journal of Clinical Nutrition, vol. 84, no. 1, pp. 252–262, 2006. View at: Google Scholar
  23. T. G. Lohman, A. F. Roche, and R. Martorell, Anthropometric Standardization Reference Manual, Human Kinetics Books, Champaign, Ill, USA, 1988.
  24. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione, Tabelle di Composizione Degli Alimenti, EDRA, Milano, Italy, 2000.
  25. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996. View at: Publisher Site | Google Scholar
  26. G. Maiani, G. Pappalardo, A. Ferro-Luzzi et al., “Accumulation of β-carotene in normal colorectal mucosa and colonic neoplastic lesions in humans,” Nutrition & Cancer, vol. 24, pp. 23–31, 1995. View at: Google Scholar
  27. S. A. Margolis and R. M. Schapira, “Liquid chromatographic measurement of L-ascorbic acid and D-ascorbic acid in biological samples,” Journal of Chromatography B: Biomedical Applications, vol. 690, no. 1-2, pp. 25–33, 1997. View at: Publisher Site | Google Scholar
  28. M. Serafini, R. Bugianesi, M. Salucci, E. Azzini, A. Raguzzini, and G. Maiani, “Effect of acute ingestion of fresh and stored lettuce (Lactuca sativa) on plasma total antioxidant capacity and antioxidant levels in human subjects,” British Journal of Nutrition, vol. 88, no. 6, pp. 615–623, 2002. View at: Publisher Site | Google Scholar
  29. T. M. Wallace, J. C. Levy, and D. R. Matthews, “Use and abuse of HOMA modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004. View at: Publisher Site | Google Scholar
  30. Anthropometry Procedures Manual, National Health and Nutrition Examination Survey, Atlanta, Ga, USA, 2007.
  31. M. Kawser Hossain, A. Abdal Dayem, J. Han et al., “Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids,” International Journal of Molecular Sciences, vol. 17, no. 4, article 569, 2016. View at: Publisher Site | Google Scholar
  32. T. Tsuda, “Recent progress in anti-obesity and anti-diabetes effect of berries,” Antioxidants, vol. 5, no. 2, article 13, 2016. View at: Publisher Site | Google Scholar
  33. F. Salamone, G. L. Volti, L. Titta et al., “Moro orange juice prevents fatty liver in mice,” World Journal of Gastroenterology, vol. 18, no. 29, pp. 3862–3868, 2012. View at: Publisher Site | Google Scholar
  34. B. Jayaprakasam, L. K. Olson, R. E. Schutzki, M.-H. Tai, and M. G. Nair, “Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in cornelian cherry (Cornus mas),” Journal of Agricultural and Food Chemistry, vol. 54, no. 1, pp. 243–248, 2006. View at: Publisher Site | Google Scholar
  35. L. Titta, M. Trinei, M. Stendardo et al., “Blood orange juice inhibits fat accumulation in mice,” International Journal of Obesity, vol. 34, no. 3, pp. 578–588, 2010. View at: Publisher Site | Google Scholar
  36. T. B. Cesar, N. P. Aptekmann, M. P. Araujo, C. C. Vinagre, and R. C. Maranhão, “Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects,” Nutrition Research, vol. 30, no. 10, pp. 689–694, 2010. View at: Publisher Site | Google Scholar
  37. G. K. Z. S. Dourado and T. B. Cesar, “Investigation of cytokines, oxidative stress, metabolic, and inflammatory biomarkers after orange juice consumption by normal and overweight subjects,” Food and Nutrition Research, vol. 59, Article ID 42798, 2015. View at: Publisher Site | Google Scholar
  38. L. G. Basile, C. G. Lima, and T. B. César, “Daily intake of pasteurized orange juice decreases serum cholesterol, fasting glucose, and diastolic blood pressure in adults,” Proceedings of the Florida State Horticultural Society, vol. 123, pp. 228–233, 2010. View at: Google Scholar
  39. R. Deopurkar, H. Ghanim, J. Friedman et al., “Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of toll-like receptor-4 and suppressor of cytokine signaling-3,” Diabetes Care, vol. 33, no. 5, pp. 991–997, 2010. View at: Publisher Site | Google Scholar
  40. E. M. Kurowska, J. D. Spence, J. Jordan et al., “HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia,” American Journal of Clinical Nutrition, vol. 72, no. 5, pp. 1095–1100, 2000. View at: Google Scholar
  41. J. M. Roza, Z. Xian-Liu, and N. Guthrie, “Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects,” Alternative Therapies in Health and Medicine, vol. 13, no. 6, pp. 44–48, 2007. View at: Google Scholar
  42. J.-P. Bastard, M. Maachi, C. Lagathu et al., “Recent advances in the relationship between obesity, inflammation, and insulin resistance,” European Cytokine Network, vol. 17, no. 1, pp. 4–12, 2006. View at: Google Scholar
  43. D.-H. Lee, A. R. Folsom, L. Harnack, B. Halliwell, and D. R. Jacobs Jr., “Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes?” American Journal of Clinical Nutrition, vol. 80, no. 5, pp. 1194–1200, 2004. View at: Google Scholar
  44. D. Li, Y. Zhang, Y. Liu, R. Sun, and M. Xia, “Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients,” Journal of Nutrition, vol. 145, no. 4, pp. 742–748, 2015. View at: Publisher Site | Google Scholar
  45. S. Asgary, M. Keshvari, M. R. Afshani, M. Amiri, I. Laher, and S. H. Javanmard, “Effect of fresh orange juice intake on physiological characteristics in healthy volunteers,” ISRN Nutrition, vol. 2014, Article ID 405867, 7 pages, 2014. View at: Publisher Site | Google Scholar
  46. T. Hajri, H. Tao, J. Wattacheril, P. Marks-Shulman, and N. N. Abumrad, “Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6,” American Journal of Physiology—Endocrinology and Metabolism, vol. 300, no. 2, pp. E350–E360, 2011. View at: Publisher Site | Google Scholar
  47. P. Peraldi and B. Spiegelman, “TNF-α and insulin resistance: summary and future prospects,” Molecular and Cellular Biochemistry, vol. 182, no. 1-2, pp. 169–175, 1998. View at: Publisher Site | Google Scholar
  48. A. V. B. Castro, C. M. Kolka, S. P. Kim, and R. N. Bergman, “Obesity, Insulin resistance and comorbidities—mechanisms of association,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 58, no. 6, pp. 600–609, 2014. View at: Publisher Site | Google Scholar
  49. A. Stears, S. O'Rahilly, R. K. Semple, and D. B. Savage, “Metabolic insights from extreme human insulin resistance phenotypes,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 26, no. 2, pp. 145–157, 2012. View at: Publisher Site | Google Scholar

Copyright © 2017 E. Azzini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.